Anxiety in patients with breast cancer undergoing treatment: A systematic review.

JBI Libr Syst Rev

1 Lim Chi Ching Honours Student Alice Lee Centre for Nursing Studies National University of Singapore (NUS) Mobile: 96338590 Email: 2 M Kamala Devi MSc Adv Practice (Cancer Care), PGDipHE, BHSc(N), ONC, RN Senior Lecturer Alice Lee Centre for Nursing Studies Yong Loo Lin School of Medicine National University of Singapore (NUS) Block E3A, Level 3 7 Engineering Drive 1 Singapore 117574 Mobile: 98310611 Phone: 6516 7792 Email: 3 Dr. Emily Ang Neo Kim DNurs, MN, BNCert. Edu., ONC, CCNC, RN DNurs Candidate University of Adelaide, South Australia Deputy Director (Clinical and Oncology Nursing) National Cancer Institute Singapore (NCIS) National University Hospital, Singapore Main Building, Level 2 5 Lower Kent Ridge Road Singapore 119074 Institution mainline: 67724819 Mobile: 96539617 Email:

Published: January 2009

Download full-text PDF

Source
http://dx.doi.org/10.11124/01938924-200907341-00012DOI Listing

Publication Analysis

Top Keywords

anxiety patients
4
patients breast
4
breast cancer
4
cancer undergoing
4
undergoing treatment
4
treatment systematic
4
systematic review
4
anxiety
1
breast
1
cancer
1

Similar Publications

Erlotinib-induced Perioral Lesions Resembling Scleroderma.

Acta Dermatovenerol Croat

November 2024

Constantin A. Dasanu MD, PhD, Lucy Curci Cancer Center, Eisenhower Health, 39000 Bob Hope Dr, Rancho Mirage, CA 92270 , USA;

Erlotinib, an epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is currently used in the therapy of several solid malignancies. This agent has been associated with several dermatological side-effects, the most common being papulo-pustular acneiform rash. Herein we describe a unique skin effect in a patient treated with erlotinib for non-small cell lung cancer.

View Article and Find Full Text PDF

Debilitating anxiety is pervasive in the modern world. Choices to approach or avoid are common in everyday life and excessive avoidance is a cardinal feature of all anxiety disorders. Here, we used intracranial EEG to define a distributed prefrontal-limbic circuit dynamics supporting approach and avoidance.

View Article and Find Full Text PDF

Background: Recurrent symptom-relevant negative autobiographical memories are common in patients with emotional disorders such as anxiety and depression, even among those without a trauma-related diagnosis. Recurrent negative autobiographical memories may also contribute to distress in non-clinical populations.

Methods: To examine the prevalence of recurrent negative autobiographical memories and associated psychological features, we recruited a student sample ( = 101) and a treatment-seeking sample of patients with emotional disorders ( = 123).

View Article and Find Full Text PDF

Complex regional pain syndrome (CRPS) is a chronic pain disorder characterized by severe, disproportionate pain relative to an inciting event. The disorder's pathophysiology is complex, involving both central and peripheral nervous system alterations, alongside genetic, inflammatory, and psychological factors. Using data from TriNetX, this study investigated the impact of analgesic and adjuvant therapies on psychiatric outcomes in CRPS patients.

View Article and Find Full Text PDF

Background: As mental health awareness increases, healthcare professionals must understand the interplay between chronic gastrointestinal (GI) conditions and psychological well-being, particularly regarding healthcare utilization. This study uniquely aggregates various chronic GI disorders, such as inflammatory bowel disease, celiac disease, and eosinophilic esophagitis, to examine their impact on depression and anxiety.

Methods: Utilizing a retrospective observational design, we analyzed data from 34,876 patients admitted to HCA national hospitals from January 2016 to December 2022.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!